FINHUB Insights

LH · Q2 FY26 · Apr 1 – Jun 30, 2026

Labcorp Q2 FY26: where the revenue came from and where it went

Labcorp Q2 FY26: revenue $3.7B (+6% year over year). Net profit $0.30B. Largest cohort Diagnostics $2.9B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2026
Reported
Aug 5, 2026 10-Q
Sankey diagram of Labcorp's income statement for Q2 FY26: revenue of $3.73 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$3.73B +6% year over year
Gross profit$1.11B 30% margin
Operating profit$0.45B 12% margin
Net profit$0.30B 8% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
ItemValueShare of revenueYear over year
Revenue 3.73 100% +6%
Diagnostics 2.90 78% +6%
Biopharma laboratory 0.84 22% +7%
Cost of revenue−2.6270%
Gross profit1.1130% margin+0pp
SG&A−0.5815%−1pp
Other−0.082%+0pp
Operating profit0.4512% margin+1pp
Tax−0.09
Interest & other costs−0.07
Net profit0.308%+1pp
Filing on EDGAR More quarters of LH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.